Latest News
-
2024-04-24
PharmaEngine announces first patient dosed in Phase I trial of PEP07 for solid tumor cancers
-
2024-03-24
ONIVYDE® obtains positive opinion from EMA's CHMP for new regimen in First-line Treatment of Metastatic PDAC
-
2024-03-18
ONIVYDE® obtains TFDA Approval for the new regimen in First-line Treatment of Metastatic PDAC